The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 05, 2024
Filed:
Apr. 16, 2021
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, CN;
Wuhan Institute of Virology, Chinese Academy of Science, Wuhan, CN;
Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, CN;
Vigonvita Life Sciences Co., Ltd., Suzhou, CN;
Yuanchao Xie, Shanghai, CN;
Gengfu Xiao, Wuhan, CN;
Yang He, Shanghai, CN;
Leike Zhang, Wuhan, CN;
Haji Akber Aisa, Xinjiang, CN;
Hualiang Jiang, Shanghai, CN;
Jingshan Shen, Shanghai, CN;
Abstract
The present invention relates to an antiviral application of nucleoside analogs. Specifically, the present invention relates to uses of nucleoside analogs and a pharmaceutical composition thereof as: (a) inhibitors for inhibiting the replication of coronaviruses, influenza viruses, respiratory syncytial viruses, flaviviridae viruses, filoviridae viruses and/or porcine epidemic diarrhea virus (PEDV); and/or (b) medicines for treating and/or preventing and mitigating diseases caused by coronavirus, influenza virus, respiratory syncytial virus, flaviviridae virus, filoviridae virus and/or porcine epidemic diarrhea virus (PEDV) infections. The nucleoside analogs according to the invention may treat and/or prevent and mitigate respiratory infection, pneumonia (COVID-19) and other related diseases caused by 2019 novel coronavirus infection.